In Burundi, the current pregnant women living with hiv antiretroviral therapy coverage for pmtct is 85%, which reflects a decrease of 10% (-10.5%) compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Burundi
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Burundi
PMTCT antiretroviral therapy coverage
More indicators for Burundi
Male unintentional poisoning
3.8
-0.1
(2019)
Female wasting in children
4.6%
+0.6%
(2020)
Female prevalence of HIV
0.4%
-0.1%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar18
+intl dollar1
(2021)
Birth registration
83.5%
+8.3%
(2017)
Contraceptive modern method prevalence
22.9%
-7.1%
(2017)
Burundi PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 85% | -10% |
| 2021 | 95% | -3% |
| 2020 | 98% | +76% |
| 2009 | 22% | +22% |
| 2008 | 0% | 0% |
| 2007 | 0% | 0% |
| 2006 | 0% | 0% |
| 2005 | 0% | 0% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |